Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Injectco vs LumiMeds

Injectco
Graded #241

Lower grade

vs+3.8000000000000114
LumiMeds
Graded #152

Higher grade

The verdict

LumiMeds takes it — 68.4/100 to 64.6/100.

LumiMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumiMeds +4
72
76
Dose & formulationEven
64
64
Clinical oversightLumiMeds +11
71
82
Labs & monitoringEven
53
53
FulfillmentLumiMeds +5
60
65
Contract termsEven
55
55
Injectco · left barLumiMeds · right bar

The numbers

MetricInjectcoLumiMeds
WeighScore64.6/10068.4/100
GradeCC
Scorecard rank#241#152
Semaglutide$156/mo (compounded)$133/mo (starting dose, compounded)
Tirzepatide$425/mo (starting dose, compounded)$133/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Injectco

Graded #241 · C

Strengths

  • Physical address in Dallas TX
  • Founded July 2021 — established
  • Bulk pricing ($1,249 for 6-8 months) can be cost-effective
  • Payment plan available ($156/mo)

Where it loses points

  • Does not specify which GLP-1 drug (semaglutide vs tirzepatide)
  • No LegitScript or PCAB accreditation
  • Primarily a medspa (Botox, fillers, hair restoration)
  • May be Texas-only — unclear if telehealth ships nationally
  • No named pharmacy partners
LumiMeds

Graded #152 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard